Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Allard, Guy Paul. Director active across 1 company, notably LSL Pharma Group Inc.. In total, 6 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 June 2026. The latest transaction was filed on 2 July 2026 (10 - Acquisition or disposition in the public market). Regulator: SEDI. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Allard, Guy Paul is a declarant linked to LSL Pharma Group Inc. (XTSE), where he is 5 - Senior Officer of Issuer. Across 6 filings in total, the 6 sampled filings between 2026-06-16 and 2026-07-06 are mainly public-market acquisitions, with buys totaling EUR 4783 and no reported sales.